First Affirmative Financial Network Has $273,000 Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

First Affirmative Financial Network raised its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 29.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,602 shares of the company’s stock after buying an additional 4,736 shares during the period. First Affirmative Financial Network’s holdings in Takeda Pharmaceutical were worth $273,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Versant Capital Management Inc bought a new stake in Takeda Pharmaceutical during the 4th quarter worth $26,000. Wilmington Savings Fund Society FSB bought a new stake in shares of Takeda Pharmaceutical during the third quarter worth about $40,000. BNP Paribas Financial Markets increased its stake in shares of Takeda Pharmaceutical by 416.0% in the third quarter. BNP Paribas Financial Markets now owns 3,220 shares of the company’s stock valued at $46,000 after buying an additional 2,596 shares during the period. Smithfield Trust Co increased its stake in shares of Takeda Pharmaceutical by 76.9% in the third quarter. Smithfield Trust Co now owns 3,428 shares of the company’s stock valued at $49,000 after buying an additional 1,490 shares during the period. Finally, Erste Asset Management GmbH acquired a new stake in Takeda Pharmaceutical during the 3rd quarter worth approximately $52,000. Institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Trading Up 2.7 %

TAK opened at $13.68 on Friday. The company’s 50 day moving average price is $13.30 and its two-hundred day moving average price is $13.89. The firm has a market capitalization of $43.51 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 0.25 and a beta of 0.51. Takeda Pharmaceutical Company Limited has a fifty-two week low of $12.57 and a fifty-two week high of $15.08. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.28 and a quick ratio of 0.77.

Takeda Pharmaceutical (NYSE:TAK) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.08. Takeda Pharmaceutical had a return on equity of 10.00% and a net margin of 6.49%. As a group, research analysts predict that Takeda Pharmaceutical Company Limited will post 1.55 earnings per share for the current year.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.